Please join us for the Finnish–U.S. Life Science Accelerator Forum 2026 with DNB Carnegie Backbay, a high-level event bringing together leaders from across the Atlantic to explore innovation, investment, and collaboration in life sciences and health technology.
This forum will feature an outstanding group of speakers, including MD, PhD Leena Niemistö, board professional, Finnish business executive, and prominent health-tech angel investor; Andreas Dirnagl, Senior Adviser, DNB Healthcare; Jarmo Sareva, Consul General of Finland in New York; Rami Jokela, CEO, Solar Foods (alternative protein and food tech); Antti Vuolanto, CEO, Herantis (biotech, neurodegenerative diseases); Juho Himberg, CEO, Optomed (medical imaging and diagnostics); Mikko Karvinen, CEO, Nexstim (neurotechnology and brain stimulation); Jukka Tapaninen, CEO, Aiforia (AIbased medical imaging and diagnostics), and MD Jonathan Gertler, Managing Partner&CEO, BackBay Life Science Advisors along with other inspiring speakers, panelists, and moderators.
The day will feature insightful keynote talks, engaging panel discussions, and valuable networking opportunities. Themes include:
- How Finnish healthcare and life science companies navigate this moment in the U.S
- Policy Landscape – Healthcare in a Changing Trade Environment
- Backing Breakthroughs – How Smart Capital Builds Life Science Success
- From Innovation to Impact –Translating Finnish Healthcare Solutions into the U.S. System
- MedTech Innovation – The Future of Detection
- New Frontiers – Next-Generation Patient Treatment Outcomes
Following the Forum, we invite you to continue the conversation in Volvo Hall for drinks and light bites, as we conclude the day in a relaxed and collegial setting.
Sign up through link: https://luma.com/4pion0gk